Skip to main navigation
Home
Company
Overview
Board of Directors
Management Team
Corporate Governance
Contact Us
Product Candidates
Product Candidates Overview
Cardiovascular Diseases
Spine Orthopedic Disorders
Oncology & Hematology
Immune-Mediated & Inflammatory Conditions
Clinical Trials
Science
Mesenchymal Lineage Cells
Mechanisms of Action
Manufacturing
Intellectual Property
Scientific Publications
Partnerships
Overview
Investors & Media
Investor Relations
At A Glance
Overview
Corporate Governance
Board of Directors
Management Team
Company Announcements
ASX Announcements
Share Price & Tools
Stock Quote & Chart
Historical Lookup
Calculator
Events & Presentations
Events Calendar
Webcasts & Presentations
Financial Information
SEC Filings
Annual Reports
Financial Reports
Analyst Coverage
Earnings Estimates
Financial Fundamentals
Shareholder Services
ADR Trading FAQs
Information Request
E-mail Alerts
Contact Us
Careers
Current Opportunities
Home
Contact Us
Company
Overview
Board of Directors
Management Team
Corporate Governance
Contact Us
Product Candidates
Product Candidates Overview
Cardiovascular Diseases
Spine Orthopedic Disorders
Oncology & Hematology
Immune-Mediated & Inflammatory Conditions
Clinical Trials
Science
Mesenchymal Lineage Cells
Mechanisms of Action
Manufacturing
Intellectual Property
Scientific Publications
Partnerships
Overview
Investors & Media
Header investor menu
At a Glance
Company Announcements
Share Price & Tools
Events and Presentations
Financial Information
Shareholder Services
Careers
Current Opportunities
INVESTORS & MEDIA CONTACTS
INVESTORS & MEDIA CONTACTS
Schond Greenway
Investor Relations
T:
+ 1 212 880 2060
E:
[email protected]
Investor Relations
At A Glance
Overview
Corporate Governance
Board of Directors
Management Team
Company Announcements
ASX Announcements
Share Price & Tools
Stock Quote & Chart
Historical Lookup
Calculator
Events & Presentations
Events Calendar
Webcasts & Presentations
Financial Information
SEC Filings
Annual Reports
Financial Reports
Analyst Coverage
Earnings Estimates
Financial Fundamentals
Shareholder Services
ADR Trading FAQs
Information Request
E-mail Alerts
Contact Us
Tools
Print Page
RSS Feeds
Email Alerts
Contacts
Share Price : as of Mar 24, 2021
